The University of Texas MD Anderson Cancer Center A Comprehensive Board Review in Hematology and Medical Oncology 2026

Description

+ Include:  videos + file sub vtt +  pdf, size:  GB

+ Target Audience: Medical Oncologists, Hematologists, Thoracic Surgeons, Otolaryngologists (Head and Neck Surgeons), Endocrinologists, Neuro-Oncologists (Neurological Surgeons)

+ Sample video: contact me for sample video

+ Information:

The course is a 6-day comprehensive review of current standards and practices in the management of patients with blood disorders and malignancy. The course is designed to enable the participant to effectively prepare for the American Board of Internal Medicine certification and recertification examinations in Hematology and Medical Oncology. Advances in clinical pharmacology, molecular genetics and risk assessment, and radiation oncology will be included.

Learning Objectives

At the conclusion of this activity, learners will be able to:

• Apply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology.

• Utilize current standards of care for patients with cancer, blood disorders and malignancies.

• Demonstrate proficiency of knowledge in hematology and medical oncology.

• Incorporate recent advances in management of hematologic and oncologic patients.

Target Audience

Specialties: Colon and Rectal Surgery, Gynecologic Oncology, Hematology, Medical Oncology, Neurological Surgery, Obstetrics and Gynecology, Thoracic Surgery, Urology

Professions: Nurse – APRN, Nurse – LVN, Nurse – RN, Pharmacist, Pharmacy Technician, Physician (MD or DO), Student or Trainee.

Best for Medical Oncologists, Hematologists, Thoracic Surgeons, Otolaryngologists (Head and Neck Surgeons), Endocrinologists, Neuro-Oncologists (Neurological Surgeons), Gynecologic Oncologists, Palliative Care Physicians, Medical Geneticists, Breast Surgical Oncologists, Urologists, Dermatologists, Gastroenterologists, Infectious Disease Specialists, Transfusion Medicine Specialists, and Hematopathologists.

Topics

• Monday, September 14, 2026

  • Welcome and Introduction

  • Early Stage and Locally Advanced Non-Small Cell Lung Cancer

  • Metastatic Non-Small Cell Lung Cancer

  • Small Cell Lung Cancer

  • Head and Neck Cancer

  • Thyroid Cancer

  • Q & A Panel Discussion (Lung Cancer, Head and Neck Cancer, Thyroid Cancer)

  • ASH ASCO Choosing Wisely Recommendations

  • Neuro-Oncology

  • Cervical Cancer and Endometrial Cancer

  • Ovarian Cancer and Unusual Ovarian Histologies

  • Palliative Care

  • Q & A Panel Discussion (Neuro-Oncology, Gynecologic Oncology, Palliative Care)

  • Solid Tumor Q & A Session 1: Lung Cancer, Head and Neck Cancer, Thyroid Cancer, Neuro-Oncology, Gynecologic Oncology

• Tuesday, September 15, 2026

  • Pharmacology I: Chemotherapy

  • Pharmacology II: Targeted Therapy (Alk, EGFR, VEGR, HER2, HH, mTOR)

  • Genetic Risk Factors

  • Sarcoma

  • Q & A Panel Discussion (Pharmacology, Genetic Risk Factors, Sarcoma)

  • Screening/Local Management of Breast Cancer

  • Systemic Treatment of Primary Breast Cancer

  • Metastatic Breast Cancer

  • Special Issues in Breast Cancer

  • Q & A Panel Discussion (Breast Cancer)

  • Solid Tumor Q & A – Session 2: Pharmacology / Genetic Risk Factors / Sarcoma / Breast Cancer

• Wednesday, September 16, 2026

  • Testicular Cancer

  • Urothelial Cancer

  • Renal Cell Carcinoma

  • Prostate Cancer

  • Melanoma

  • Q & A Panel Discussion (Genitourinary Oncology, Melanoma)

  • Pancreaticobiliary Cancers / Unknown Primary

  • Gastroesophageal Cancers / Hepatocellular Carcinoma

  • Colorectal Cancer: Biology and Adjuvant Therapy

  • Metastatic Colorectal Cancer and Anal Cancer

  • Q & A Panel Discussion (Gastrointestinal Oncology)

  • Solid Tumor Q & A – Session 3: Genitourinary Oncology / Gastrointestinal Oncology / Melanoma

• Thursday, September 17, 2026

  • Chronic Myeloid Leukemia

  • Myeloproliferative Neoplasms

  • Myelodysplastic Syndrome

  • Acute Lymphoblastic Leukemia

  • Stem Cell Transplant Supportive Care

  • Q & A Panel Discussion (MPN, MDS, Leukemia, SCT)

  • Chronic Lymphocytic Leukemia and Hairy Cell Leukemia

  • Acute Myeloid Leukemia

  • Management of Cellular and Immune Based Therapies in Cancer

  • Infectious Complications in Patients with Hematologic Malignancies

  • Targeted Therapies in Hematologic Malignancies

  • Q & A Panel Discussion (Leukemia, Therapies, Infectious Complications)

  • Malignant Hematology Q & A Session

• Friday, September 18, 2026

  • Classification of Lymphoma

  • Aggressive Non-Hodgkin Lymphoma

  • Indolent Non-Hodgkin Lymphoma

  • Hodgkin Lymphoma

  • Multiple Myeloma and Other Plasma Cell Dyscrasias

  • Q & A Panel Discussion (Lymphoma, Myeloma)

  • Sickle Cell Anemias, Thalassemia, and Hemoglobinopathies

  • Approach to Anemia

  • Issues in Transfusion Medicine

  • Disorders of Platelet Function

  • Thrombocytopenias

  • Q & A Panel Discussion (Red Cell Disorders, Transfusion Medicine, Platelets)

• Saturday, September 19, 2026

  • Benign Hematology Q & A Session

  • Antithrombotic & Antiplatelet Therapy

  • Normal Coagulation

  • Coagulation Factor Deficiencies, Including von Willebrand Disease and Hemophilias

  • Hypercoagulable States

  • Q & A Panel Discussion (Coagulation, Antithrombotic Therapy)

  • Iron Deficiency and Hemochromatosis

  • Hematopoietic Growth Factors

  • Bone Marrow Failure

  • Leukopenia and Leukocytosis

  • Hemolytic Anemias

  • Q & A Panel Discussion (General Hematology Topics, Red Cell Disorders)